(115 days)
The MINISPACER® 1024A, 1025A and 1543A adapters are single patient, disposable devices for dispensing pressurized metered dose inhaler (pMDI) medication into a breathing circuit, as prescribed by a physician or other licensed health care practitioner.
The MINISPACER® 1024A, 1025A and 1543A adapters are indicated for patients on a breathing circuit, for whom aerosol medication has been prescribed, in short and long term critical care environments.
Not Found
My deepest apologies, but the provided text does not contain specific acceptance criteria or the details of a study that proves a device meets those criteria. The document is an FDA 510(k) clearance letter for the MiniSpacer® 1024A, 1025A, and 1543A MDI Adapters.
This type of document is a regulatory approval, stating that the device is "substantially equivalent" to legally marketed predicate devices. It confirms that the FDA has reviewed the manufacturer's submission and found it acceptable for market, but it does not typically include:
- A table of acceptance criteria and reported device performance.
- Details about sample size, data provenance, expert qualifications, or adjudication methods for a test set.
- Information on Multi-Reader Multi-Case (MRMC) comparative effectiveness studies or standalone algorithm performance.
- Specifics about the type of ground truth used or the size and establishment of ground truth for a training set.
These details would normally be found in the V&V (Verification and Validation) reports or clinical study summaries submitted by the manufacturer to the FDA as part of their 510(k) application, but they are not typically included in the public-facing clearance letter itself.
Therefore, I cannot fulfill your request for this specific document. If you have a different document that details performance studies, I would be happy to analyze it.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows a circular logo with text around the perimeter and a stylized bird-like symbol in the center. The text around the perimeter appears to be part of an organization's name or motto. The bird-like symbol is composed of three curved lines that suggest the shape of a bird in flight. The logo has a simple, clean design and is likely used to represent a government agency or non-profit organization.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room WO66-G6(F) Silver Spring, MD 20993-0002
Ms. Ericka S. Strickland Director of Regulatory Affairs Thaver Medical Corporation 4575 South Palo Verde Road. Suite 337 Tucson, Arizona 85714
SEP 2 19 2011
Re: K111570
Trade/Device Name: MiniSpacer® 1024A. 1025A and 1543A MDI Adapter Regulation Number: 21 CFR 868.5630 Regulation Name: Nebulizer Regulatory Class: II Product Code: CAF Dated: September 22. 2011 Received: September 23, 2011
Dear Ms. Strickland:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 – Ms. Strickland
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies, You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem /default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicallDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Nhi for
Anthony D. Watson, B.S., M.S., M.B.A. -Director
Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known):
Device Name: MiniSpacer® 1024A, 1025A and 1543A MDI Adapter
Indications For Use:
The MINISPACER® 1024A, 1025A and 1543A adapters are single patient, disposable devices for dispensing pressurized metered dose inhaler (pMDI) medication into a breathing circuit, as prescribed by a physician or other licensed health care practitioner.
The MINISPACER® 1024A, 1025A and 1543A adapters are indicated for patients on a breathing circuit, for whom aerosol medication has been prescribed, in short and long term critical care environments.
Prescription Use x (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Dan Cilla de la Torrebellis 9/29/11
(Division Sign Off)
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K111520
§ 868.5630 Nebulizer.
(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).